
Pioneering trial gives cervical cancer patient a second life
After being told she had less than a year to live from stage 3 cervical cancer, Aricca Wallace joined a National Cancer Institute–Rutgers trial in 2012, where doctors engineered immune cells to attack her tumor; following surgery and treatment, her cancer became undetectable by December 2012 and she has remained cancer-free for over 13 years, now sharing her story to advocate for self-advocacy and awareness while researchers continue to refine cell-based therapies.







